 suppressive treatment rheumatoid arthritis intravenous methylprednisolone nitrogen mustard Persistent polyarticular rheumatoid arthritis RA aggressive disease resistant conventional therapy intravenous pulse methylprednisolone IVMP nitrogen mustard efficacy toxicity immunologic effects agent Clinical response evident days start therapy weeks IVMP days Morbidity agents minimal appropriate precautions mortalities modality RA